Escitalopram versus paroxetine controlled release in major depressive disorder: a randomized trial-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Escitalopram versus paroxetine controlled release in major depressive disorder: a randomized trial

Published:2017-01 Issue: Volume:Volume 13 Page:117-125
ISSN:1178-2021
Container-title:Neuropsychiatric Disease and Treatment
language:en
Short-container-title:NDT

Author:

Kishi Taro,Matsuda Yuki,Matsunaga Shinji,Moriwaki Masatsugu,Otake Yoichiro,Akamatsu Kaku,Okochi Tomo,Hirano Shigeki,Funahashi Toshihiko,Okuda Momoko,Tabuse Hideaki,Fujita Kiyoshi,Iwata Nakao

Publisher

Informa UK Limited

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Escitalopram versus other antidepressive agents for major depressive disorder: a systematic review and meta-analysis;BMC Psychiatry;2023-11-24

2. Alternate day dTMS combined with SSRIs for chronic treatment resistant depression: A prospective multicenter study;Journal of Affective Disorders;2018-11

3. Safety Limits of Antidepressant Use Plus Combinations: Focus on Cardiovascular Function;Current Drug Metabolism;2018-07-20

4. Comparative effectiveness of switching paroxetine formulation for treatment of major depressive disorder: an open-label multicenter study;Neuropsychiatric Disease and Treatment;2018-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP